Presentation Information
[S37-3]Understanding mechanisms of resistance to molecular-targeted drugs by analyzing cancer patient derived specimens and molecular dynamics simulations
○Ryohei Katayama1,2, Mitsugu Araki3 (1. Cancer Chemother Ctr, JFCR, 2. Grad Sch Fronti Sci, Univ of Tokyo, 3. Grad Sch Med, Kyoto Univ)